Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Biochemical Pharmacology
|
February 21, 2022
Functional roles of neuromedin B and gastrin-releasing peptide in regulating itch and pain in the spinal cord of non-human primates
Norikazu Kiguchi, Huiping Ding, Sun H Park, et al.
Frontiers in Oncology
|
November 16, 2020
A Short-Term Effect of Wearable Technology-Based Lifestyle Intervention on Body Composition in Stage I-III Postoperative Breast Cancer Survivors
Changming Zhou, Miao Mo, Zezhou Wang, et al.
Science Translational Medicine
|
August 31, 2018
A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates
Huiping Ding, Norikazu Kiguchi, Dennis Yasuda, et al.
British Journal of Anaesthesia
|
March 28, 2019
BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates
Norikazu Kiguchi, Huiping Ding, Gerta Cami-Kobeci, et al.
European Journal of Pharmacology
|
November 23, 2016
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)
Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, et al.
Nature
|
January 14, 2021
STING controls nociception via type I interferon signalling in sensory neurons
Christopher R Donnelly, Changyu Jiang, Amanda S Andriessen, et al.
Biochemical Pharmacology
|
March 20, 2021
Usefulness of the measurement of neurite outgrowth of primary sensory neurons to study cancer-related painful complications
Sun H Park, Matthew R Eber, Miriam M Fonseca, et al.
Cell Reports
|
April 9, 2020
Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch
Santosh K Mishra, Joshua J Wheeler, Saumitra Pitake, et al.
Future Oncology (London, England)
|
March 4, 2026
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial
Shengnan Hao, Xiaomin Wang, Huiping Ding, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Biochemical Pharmacology
|
February 21, 2022
Functional roles of neuromedin B and gastrin-releasing peptide in regulating itch and pain in the spinal cord of non-human primates
Norikazu Kiguchi, Huiping Ding, Sun H Park, et al.
Frontiers in Oncology
|
November 16, 2020
A Short-Term Effect of Wearable Technology-Based Lifestyle Intervention on Body Composition in Stage I-III Postoperative Breast Cancer Survivors
Changming Zhou, Miao Mo, Zezhou Wang, et al.
Science Translational Medicine
|
August 31, 2018
A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates
Huiping Ding, Norikazu Kiguchi, Dennis Yasuda, et al.
British Journal of Anaesthesia
|
March 28, 2019
BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates
Norikazu Kiguchi, Huiping Ding, Gerta Cami-Kobeci, et al.
European Journal of Pharmacology
|
November 23, 2016
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)
Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, et al.
Nature
|
January 14, 2021
STING controls nociception via type I interferon signalling in sensory neurons
Christopher R Donnelly, Changyu Jiang, Amanda S Andriessen, et al.
Biochemical Pharmacology
|
March 20, 2021
Usefulness of the measurement of neurite outgrowth of primary sensory neurons to study cancer-related painful complications
Sun H Park, Matthew R Eber, Miriam M Fonseca, et al.
Cell Reports
|
April 9, 2020
Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch
Santosh K Mishra, Joshua J Wheeler, Saumitra Pitake, et al.
Future Oncology (London, England)
|
March 4, 2026
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial
Shengnan Hao, Xiaomin Wang, Huiping Ding, et al.
Page
of 5